Automated Immunoassay Analysers Market Size Poised to Reach USD 34.25 Billion by 2030

The global automated immunoassay analysers market, valued at USD 12.12 billion in 2023, is projected to reach nearly USD 34.25 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 16% during the forecast period from 2024 to 2030.

Market Definition and Overview

Automated Immunoassay Analysers Market Size are sophisticated laboratory instruments designed to detect and quantify specific substances, such as antigens, antibodies, hormones, and pathogens, in biological samples. By automating the immunoassay process, these analysers enhance accuracy, efficiency, and throughput in diagnostic laboratories, hospitals, and research institutions. Their applications span various fields, including clinical diagnostics, pharmaceutical development, and biotechnology research.

Growth Drivers and Opportunities

Several factors contribute to the significant growth of the automated immunoassay analysers market:

• Advancements in Laboratory Automation: The integration of automation in laboratories has streamlined workflows, reduced manual errors, and increased testing capacities. Innovations in immunoassay technologies have led to the development of analysers capable of high-throughput and multiplex testing, meeting the growing demand for efficient diagnostic solutions.

• Rising Prevalence of Infectious Diseases: The global increase in infectious diseases necessitates rapid and accurate diagnostic tools. Automated immunoassay analysers offer timely detection and monitoring of these diseases, aiding in effective patient management and control measures.

• Pharmaceutical and Biotechnology Applications: Pharmaceutical and biotechnology companies are increasingly utilizing automated immunoassay analysers for drug discovery and development. These instruments facilitate the identification and quantification of biomarkers, accelerating the development of targeted therapies and personalized medicine.

• Favorable Government Policies: Supportive government initiatives promoting advanced diagnostic technologies and healthcare infrastructure development further propel market growth. Investments in healthcare modernization and disease surveillance systems create a conducive environment for the adoption of automated immunoassay analysers.

Request For Free Sample:  https://www.maximizemarketresearch.com/request-sample/11000/ 

Segmentation Analysis

The automated immunoassay analysers market is segmented based on technology, sales model, application, and end-user:

• By Technology:

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-Linked Fluorescent Immunoassay (ELFA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • Others

• By Sales Model:

  • Reagent Rental/Lease
  • Outright Sale

• By Application:

  • Infectious Diseases
  • Endocrinology
  • Drug Monitoring
  • Cardiology
  • Oncology
  • Allergy Testing
  • Others

• By End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Others

Regional Insights

• North America: Dominating the market, North America benefits from the strategic presence of key manufacturers, high adoption of advanced technologies, and a strong demand for efficient immunoassay analysers. In 2023, the U.S. contributed over 85% to the regional revenue share, driven by favorable government policies and rapid adoption of automation in diagnostic laboratories.

• Asia-Pacific: This region is expected to witness the highest growth rate, particularly led by China. Factors such as improving healthcare infrastructure, a large patient pool requiring diagnostic testing, and the entry of leading manufacturers contribute to the promising growth prospects in the coming years.

Country-Level Analysis

• United States: The U.S. market is characterized by a high adoption rate of automated immunoassay analysers, supported by technological advancements and a well-established healthcare system. The focus on early disease detection and personalized medicine drives the demand for sophisticated diagnostic tools.

• Germany: As a leading market in Europe, Germany accounted for the largest revenue share of 23.7% in 2020. The country's strong healthcare infrastructure, coupled with a high prevalence of chronic diseases, fuels the demand for advanced immunoassay analysers.

Competitive Landscape

The automated immunoassay analysers market is highly competitive, with key players focusing on product innovation, strategic partnerships, and mergers and acquisitions to strengthen their market position. Major companies operating in the market include:

• Siemens Healthineers
• Abbott Laboratories
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Pall Corporation
• Beckman Coulter, Inc.
• Sigma-Aldrich Corporation
• Sartorius AG
• Ortho Clinical Diagnostics
• Radiometer APS
• Danaher Corporation
• Randox Laboratories
• F. Hoffmann-La Roche Ltd.
• DiaSorin S.p.A.
• Agilent Technologies